TY - JOUR
KW - biomedicine
KW - Biotechnology
KW - Cancer Research
KW - Medicinal Chemistry
KW - Molecular medicine
KW - Pharmacology/Toxicology
KW - general
AU - Andrew S. Robertson
AU - Nahid Latif
AU - Imein Bousnina
AU - Donna Boyce
AU - Kevin Carl
AU - Sean P. Curtis
AU - Jennifer Dudinak
AU - Carlos O. Garner
AU - Michael Garvin
AU - Sabine Luik
AU - Koen Nauwelaerts
AU - Eddie Reilly
AU - Michelle Rohrer
AU - Katrin Rupalla
AU - Jacintha Shenton
AU - Jerry Stewart
AU - Mark Taisey
AU - Axel Vicart
AU - Raymond C. Votzmeyer
AU - Matthew P. Wagoner
AU - Max Wegner
AU - Kathy Williams
AB - Clear and harmonized regulatory guidelines are needed to realize the potential of new approach methodologies for improving the predictivity of nonclinical drug candidate assessment.
BT - Nature Reviews Drug Discovery
DA - 2025-06
DO - 10.1038/d41573-025-00038-6
IS - 6
LA - en
N2 - Clear and harmonized regulatory guidelines are needed to realize the potential of new approach methodologies for improving the predictivity of nonclinical drug candidate assessment.
PY - 2025
SP - 401
EP - 402
ST - Accelerating adoption of new approach methodologies in regulatory decision making
T2 - Nature Reviews Drug Discovery
TI - Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspective
UR - https://www.nature.com/articles/d41573-025-00038-6
VL - 24
Y2 - 2025-09-29
SN - 1474-1784
ER -